Shaw Christine 4
4 · GenMark Diagnostics, Inc. · Filed Oct 29, 2020
Insider Transaction Report
Form 4
Shaw Christine
VP, Assay Development
Transactions
- Sale
Common Stock
2020-10-27$11.34/sh−68$771→ 79,646 total
Footnotes (1)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.